SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-002982
Filing Date
2020-09-02
Accepted
2020-09-02 15:34:47
Documents
4
Period of Report
2020-09-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannabics_8k.htm 8-K 12570
2 DIRECTOR RESOLUTION cannabics_ex1001.htm EX-10.1 4987
3 RESOLUTION OF THE SHAREHOLDERS cannabics_ex1002.htm EX-10.2 5320
4 GRAPHIC image_001.jpg GRAPHIC 2650
  Complete submission text file 0001683168-20-002982.txt   28112
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 201156849
SIC: 2834 Pharmaceutical Preparations